Literature DB >> 29173680

Non-ST-Segment Acute Coronary Syndromes.

Tarlan Hedayati1, Neha Yadav2, Jagadish Khanagavi3.   

Abstract

Acute coronary syndrome (ACS) represents an umbrella of ischemic myocardial disease and diagnoses encompassing unstable angina (UA), non-ST-elevation myocardial infarction (NSTEMI), and ST-elevation myocardial infarction (STEMI). UA and NSTEMI for all intents and purposes, share similar pathophysiology, but at increasing severity. This article focuses on the diagnosis, risk stratification, management, and strategies that impact outcomes in NSTEMI.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute coronary syndrome; NSTE-ACS; NSTEMI

Mesh：

Year:  2018        PMID： 29173680     DOI： 10.1016/j.ccl.2017.08.003

Source DB:  PubMed          Journal:  Cardiol Clin        ISSN： 0733-8651            Impact factor:   2.213


  10 in total

1.  Should PRECISE-DAPT be included for long-term prognostic stratification of diabetic patients with NSTEACS?

Authors:  Federico García-Rodeja Arias; Belén Álvarez Álvarez; Teba González Ferrero; Jesús Martinón Martínez; Óscar Otero García; Pablo Tasende Rey; Carla Eugenia Cacho Antonio; Charigan Abou Jokh Casas; Pilar Zuazola; Víctor Jiménez Ramos; Alberto Cordero; David Escribano; Belén Cid Álvarez; Diego Iglesias Álvarez; Rosa María Agra Bermejo; Pedro Rigueiro Veloso; José María García Acuña; Francisco Gude Sampedro; José Ramón González Juanatey
Journal:  Acta Diabetol       Date:  2021-09-13       Impact factor: 4.280

2.  The Predictive Value of Barthel Score, Sequential Organ Failure Assessment Score, and D-Dimer in the 28-Day Prognosis of Patients with Non-ST Elevation Myocardial Infarction: A Retrospective Study of 358 Patients.

Authors:  GuiYing Dai; Jun Yang; JunYu Wang; FengLi Gao; WenHong Liu; Ping Li; Bing Wei
Journal:  Int J Gen Med       Date:  2022-09-13

3.  Comparative Efficacy of Danshen Class Injections for Treating Acute Coronary Syndrome: A Multidimensional Bayesian Network Meta-Analysis of Randomized Controlled Trials.

Authors:  Siyu Guo; Jiarui Wu; Mengwei Ni; Shanshan Jia; Jingyuan Zhang; Wei Zhou; Xinkui Liu; Miaomiao Wang; Xiaomeng Zhang
Journal:  Front Pharmacol       Date:  2020-08-26       Impact factor: 5.810

4.  Drug-drug interactions in patients with acute coronary syndrome across phases of treatment.

Authors:  Ana V Pejčić; Slobodan M Janković; Goran Davidović
Journal:  Intern Emerg Med       Date:  2018-11-27       Impact factor: 3.397

5.  Roles of Morris Index on Poor Outcomes in Patients with Non-ST Segment Elevation Acute Coronary Syndrome.

Authors:  Huizhong Lin; Tao Lin; Lan Lin; Mingfang Ye
Journal:  Med Sci Monit       Date:  2020-10-19

6.  Higher Long-Term Mortality in Patients with Non-ST-Elevation Myocardial Infarction than ST-Elevation Myocardial Infarction after Discharge.

Authors:  Xiongyi Han; Liyan Bai; Myung Ho Jeong; Joon Ho Ahn; Dae Young Hyun; Kyung Hoon Cho; Min Chul Kim; Doo Sun Sim; Young Joon Hong; Ju Han Kim; Youngkeun Ahn
Journal:  Yonsei Med J       Date:  2021-05       Impact factor: 2.759

7.  Analysis of the APOB Gene and Apolipoprotein B Serum Levels in a Mexican Population with Acute Coronary Syndrome: Association with the Single Nucleotide Variants rs1469513, rs673548, rs676210, and rs1042034.

Authors:  Maricela Aceves-Ramírez; Yeminia Valle; Fidel Casillas-Muñoz; Diana Emilia Martínez-Fernández; Brenda Parra-Reyna; Víctor Arturo López-Moreno; Héctor Enrique Flores-Salinas; Emmanuel Valdés-Alvarado; José Francisco Muñoz-Valle; Texali García-Garduño; Jorge Ramón Padilla-Gutiérrez
Journal:  Genet Res (Camb)       Date:  2022-03-31       Impact factor: 1.588

8.  Value of GRACE and SYNTAX scores for predicting the prognosis of patients with non-ST elevation acute coronary syndrome.

Authors:  Xiao-Feng Wang; Ming Zhao; Fei Liu; Guo-Rong Sun
Journal:  World J Clin Cases       Date:  2021-11-26       Impact factor: 1.337

9.  The Role of Sympathetic System as a Therapeutic Option in the Ischemia/Reperfusion Injury.

Authors:  Bertha F Polegato; Leonardo A M Zornoff
Journal:  Arq Bras Cardiol       Date:  2019-10-10       Impact factor: 2.000

10.  Improved Cardiac Function and Attenuated Inflammatory Response by Additional Administration of Tirofiban during PCI for ST-Segment Elevation Myocardial Infarction Patients.

Authors:  Jing Zhang; Guomin Ding
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-16       Impact factor: 2.629
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.